Table 3.
Groups | Lymph node metastasis (n = 42)* | Distant metastasis (n = 9)† | Lymph node or distant metastasis (n = 51) |
---|---|---|---|
CSE1L-positive, cases (%) | 30 (71.4)‡ | 8 (88.9)¶ | 38 (74.5)** |
CEA-positive, cases (%) | 20 (47.6) | 7 (77.8) | 27 (52.9) |
CSE1L or CEA-positive, cases (%) | 37 (88.1)§ | 9 (100)∥ | 46 (90.2)†† |
Lymph node metastasis: N0M0, N1M0, and N2M0.
Distant metastasis: N0M1, N1M1, and N2M1.
P = 0.0009, compared with that of CEA-positive cases in the lymphatic metastasis group.
P = 0.000004, compared with that of CEA-positive cases in the lymphatic metastasis group.
P = 0.346, compared with that of CEA-positive cases in the distant metastasis group.
P = 0.169, compared with that of CEA-positive cases in the distant metastasis group.
P = 0.0005, compared with that of CEA-positive cases in the lymph node or distant metastasis group.
P < 0.0001, compared with that of CEA-positive cases in the lymph node or distant metastasis group.